Jeffrey M. Dayno

CIK 1615993 · PRESIDENT, CEO · last filed 2026-01-26

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$448.0K

Companies

2

Total Filings

30

Lifetime Open-Market Net

-$5.49M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
HRMY PRESIDENT, CEO 13,000 $34.46 $448.0K -$5.43M 16 2026-01-26
Zyla Life Sciences (EGLT) Delisted Chief Medical Officer 18,212 -$57.9K 14 2017-06-12

Recent Filings · Page 2 of 3

30 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-10-07 HRMY Mixed -$57.4K EDGAR
2021-09-09 HRMY Mixed -$293.6K EDGAR
2021-08-30 HRMY Mixed -$269.1K EDGAR
2021-08-11 HRMY Mixed -$218.8K EDGAR
2021-07-23 HRMY Mixed -$1.1K EDGAR
2020-08-20 HRMY Grant (A) $0 EDGAR
2017-06-12 Zyla Life Sciences (EGLT) Delisted Grant (A) $0 EDGAR
2017-04-04 Zyla Life Sciences (EGLT) Delisted Sell (S) −536 -$2.8K EDGAR
2017-01-04 Zyla Life Sciences (EGLT) Delisted Sell (S) −536 -$4.2K EDGAR
2016-12-08 Zyla Life Sciences (EGLT) Delisted Grant (A) $0 EDGAR
Showing 1120 of 30
Page 2 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.